New RSV vaccine called Arexy approved for people aged 60 and older
Health Canada has authorized the first RSV vaccine for people aged 60 and older.
Doctors have been calling for the vaccine for this group, which is at a higher risk of becoming severely ill from the virus.
Drugmaker GSK says during clinical trials, the drug was 82 percent effective at lowering respiratory tract disease caused by RSV.
In Canada, RSV season usually starts in the fall, and ends in the spring.

Keep Talking Justice Reform: MP
NRP Warn of Opioid Overdose Surge
Teenagers Wanted After Welland Car Crash
Nurse Practitioner Impacting Niagara Falls ER
Grimsby, Port Colborne Honour Remembrance Day
St. Catharines Man Charged with Drug Dealing
Wainfleet Man Wins Lottery... 1st Time
MP Plans to Hear More Vaccine Injury Stories